ClinicalTrials.gg
Not yet recruitingNCT07609459Updated May 27, 2026

Study Protocol: The Jerte Valley as an Inclusive Outdoor Classroom. Smart and Active Tourism.

An interventional study of Rafting, canoeing and kayaking and Divulgation in Disabilities and Visual Impairment and Blindness (Excl Colour Blindness), sponsored by Universidad de Extremadura. Not yet recruiting. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-27.

Primary conditionBlindnessRegistry: Vision DisordersReclassifiedWhy we changed it
Registry
Vision Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Blindness
Why
  1. The study's listed conditions name Blindness, a narrower term within Vision Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universidad de Extremadura · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

To promote the inclusion of people with disabilities, an outdoor intervention will be conducted involving physical activities with adolescents with and without disabilities. The study will be designed as a randomized controlled trial (RCT) with a control group that will not participate in these activities, and will include three time points (pre-intervention, post-intervention, and follow-up). The study will assess sociodemographic, accessibility, socio-emotional, and group cohesion variables.

02

Conditions studied

  • Disabilities
  • Visual Impairment and Blindness (Excl Colour Blindness)

Browse trials for

Keywords

  • visual impairment
  • disability
  • inclusion
  • physical activity
  • smart tourism
03

In context

Blindness Reclassified

144 studies on the registry are indexed under Blindness; 33 are open to participants now.

This study's planned enrollment of 35 is close to the median of 37 across 101 interventional studies indexed under Blindness.

Browse Blindness studies →

Lead sponsor

Universidad de Extremadura is the lead sponsor of 39 studies on the registry; 3 are open to participants now.

Compared within Blindness, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Vision Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 12 -16 years
  • Enrollment in public schools and special education centers
  • signed by tutors

Exclusion criteria

Exclusion Criteria:

  • Have health issues that prevent them from participating in physical activity or pose a safety risk to participants
  • Not having a signed
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Active tourism

    Participants in the experimental group will attend an informational session on disability and take part in an interactive workshop where they will experience the challenges and sensations faced by people with disabilities to empathize with them and understand their reality.Subsequent to this workshop, participants will engage in a series of activities, beginning with whitewater rafting, followed by canyoning, and concluding with kayaking. These activities are designed to be inclusive, accommodating individuals both with and without disabilities. Following workshops and activities based on smart and active tourism, the personal experiences of people with and without disabilities will be shared, fostering a dialogue that further enhances the understanding of the reality faced by people with functional diversity.

    Other: Rafting, canoeing and kayaking

  • Other
    Divulgation, not intervention

    Students will participate in a workshop on disability awareness. The workshop will be the same for this group and the group participating in outdoor physical activities. During the workshop, students will learn about disabilities and experience a simulation using eye masks and tongue depressors to simulate visual and speech impairments.

    Other: Divulgation

Interventions

  • OtherRafting, canoeing and kayaking

    Participants in the experimental group will attend an informational session on disability and take part in an interactive workshop where they will experience the challenges and sensations faced by people with disabilities to empathize with them and understand their reality.Subsequent to this workshop, participants will engage in a series of activities, beginning with whitewater rafting, followed by canyoning, and concluding with kayaking. These activities are designed to be inclusive, accommodating individuals both with and without disabilities. Following workshops and activities based on smart and active tourism, the personal experiences of people with and without disabilities will be shared, fostering a dialogue that further enhances the understanding of the reality faced by people with functional diversity.

  • OtherDivulgation

    : Students will participate in a workshop on disability awareness. The workshop will be the same for this group and the group participating in outdoor physical activities. During the workshop, students will learn about disabilities and experience a simulation using eye masks and tongue depressors to simulate visual and speech impairments.

06

What researchers measure

Primary outcomes

  1. Perception of accesibility (Physical and Social Accessibility Scale)

    This scale measures perceptions of accessibility in one's environment, focusing on physical and social aspects and considering how social interactions and inclusion influence daily life. A Likert scale ranging from 1 ( "extremely inaccessible") to 5 ( "extremely accessible ") was used to measure these perceptions.

    Time frame: Through study completion, an average of one month

  2. Perception of group cohesion (Group Environment Questionnaire)

    Assesses the perceptions of group cohesion. This questionnaire includes factors related to personal attraction to group tasks, personal motivation toward the social group, engagement in group tasks, and group-social unity.

    Time frame: Through study completion, average of 1 month

  3. Perception of attitudes towards inclusion (AISDPE)

    This scale consists of 17 items divided into two dimensions: cognitive perception (seven items) and behavioral intention (ten items). The scores were determined using a Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree").

    Time frame: Through study completion, an average of one month follow up

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jul 2026, 1 month later.

Of 36 interventional studies with no phase under Blindness, half reached primary completion within 57 months of starting (the median), counting those still running; a quarter within 19. This study's planned 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2026
First posted
May 27, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Jul 1, 2026
CompletionEst.
Aug 1, 2026
Last update
May 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07609459
Lead sponsor
Universidad de Extremadura
Responsible party
Noelia Mayordomo (Principal Investigator, Universidad de Extremadura) — Principal investigator
First posted
May 27, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Jul 1, 2026 (estimated)
Completion
Aug 1, 2026 (estimated)
Last update
May 27, 2026

Study contacts

Noelia Mayordomo-Pinilla, Master
Contact
noeliamp@unex.es
+34 569879797

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion